WES analysis of patients with USP8 wild-type corticotroph adenomas

The overall goal of the Identification of recurrent mutations in Cushing’s disease project is to study the impact of whole-exome sequencing (WES) on the clinical care of cancer patients and oncology provider practices. The aims of Project are to implement and establish the feasibility of WES in patients with USP8 wild-type corticotroph adenomas; to develop a framework for the understanding of the molecular mechanism of the pathogenesis of corticotroph adenoma.

44 samples
DAC: EGAC00001000919
Technology: Illumina HiSeq 2500

Access Policy1 Study Files

Metadata

Request Access

Policy for SH-ACTHPA Data Access

For each dataset that requires controlled access, there is a corresponding Data Access Committee (DAC) who determine access permissions. Access to actual data files is not managed by the EGA. Data access requires additional written investigator permission and the approval of Ministry of Science and Technology of P.R.C (MOST).

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID	Study Title	Study Type
	Identification of recurrent mutations in Cushing’s disease	Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID	File Type	Size	Located in